Alprostadil

History of recurrent priapism, sickle cell anaemia or trait, multiple myeloma, leukaemia, thrombocythaemia, polycythaemia, predisposition to venous thrombosis, anatomical penile deformation (e.g. angulation, cavernosal fibrosis, Peyronie's disease, stenosis of distal urethra, severe hypospadias and curvature, balanitis, acute/chronic urethritis), penile implants. Patient for whom sexual activity is inadvisable (e.g. unstable CV or cerebrovascular conditions). Concomitant use w/ other drugs for erectile dysfunction (e.g. phosphodiesterase type 5 (PDE5) inhibitors, papaverine). Neonates w/ resp distress syndrome. Childn (intracavernosal).

Patient w/ bleeding tendencies, blood-borne and pulmonary diseases, transient ischaemic attacks, CHD, CHF, history of psychiatric disorder or addiction. Pregnancy (use condom barrier if female partner is or may be pregnant). Patient Counselling This drug may cause dizziness, syncope, and hypotension, if affected, do not drive or operate machinery. Monitoring Parameters Monitor for BP, resp and heart rates, temp, degree of penile pain, duration of erection, adequate detumescence after dosing, and signs of infection.

Headache, flushing, hypotension, diarrhoea; pain, haematoma, and ecchymoses at inj site; pain during erection, fibrotic nodules, Peyronie's disease, priapism. Rarely, penile fibrosis. Apnoea, fever, bradycardia, tachycardia, convulsion, oedema, cardiac arrest, hypokalaemia, disseminated intravascular coagulation, cortical proliferation of long bones (childn).

Reduced effect w/ sympathomimetics, decongestants, and appetite suppressants. May enhance the effects of antihypertensives, vasoactive drugs, anticoagulants and platelet aggregation inhibitors.

Drugs for Erectile Dysfunction / Other Cardiovascular Drugs

G04BE01 - alprostadil ; Belongs to the class of drugs used in erectile dysfunction.
C01EA01 - alprostadil ; Belongs to the class of prostaglandins used in cardiac therapy.